Logo image of CANG

CANGO INC/KY - ADR (CANG) Stock Fundamental Analysis

NYSE:CANG - US1375861036 - ADR

4.94 USD
+0.03 (+0.61%)
Last: 8/27/2025, 1:40:02 PM
Fundamental Rating

3

Overall CANG gets a fundamental rating of 3 out of 10. We evaluated CANG against 123 industry peers in the Specialty Retail industry. CANG may be in some trouble as it scores bad on both profitability and health. CANG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CANG had negative earnings in the past year.
In multiple years CANG reported negative net income over the last 5 years.
CANG had negative operating cash flow in 4 of the past 5 years.
CANG Yearly Net Income VS EBIT VS OCF VS FCFCANG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

CANG has a Return On Assets of 0.04%. This is comparable to the rest of the industry: CANG outperforms 49.59% of its industry peers.
CANG has a Return On Equity (0.08%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.04%
ROE 0.08%
ROIC N/A
ROA(3y)-3.88%
ROA(5y)3.21%
ROE(3y)-6.46%
ROE(5y)4.15%
ROIC(3y)N/A
ROIC(5y)N/A
CANG Yearly ROA, ROE, ROICCANG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CANG has a Profit Margin (0.17%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CANG has grown nicely.
CANG's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 13.27%, CANG is not doing good in the industry: 88.62% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CANG has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 0.17%
GM 13.27%
OM growth 3Y61.58%
OM growth 5Y-5.43%
PM growth 3YN/A
PM growth 5Y6.57%
GM growth 3Y-7.64%
GM growth 5Y-20.99%
CANG Yearly Profit, Operating, Gross MarginsCANG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

More info and screens

3

2. Health

2.1 Basic Checks

CANG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CANG has about the same amount of shares outstanding.
Compared to 5 years ago, CANG has less shares outstanding
CANG has a worse debt/assets ratio than last year.
CANG Yearly Shares OutstandingCANG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CANG Yearly Total Debt VS Total AssetsCANG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

CANG has an Altman-Z score of 1.08. This is a bad value and indicates that CANG is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.08, CANG is not doing good in the industry: 69.92% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.20 indicates that CANG is not too dependend on debt financing.
CANG has a Debt to Equity ratio of 0.20. This is in the better half of the industry: CANG outperforms 63.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACC8.12%
CANG Yearly LT Debt VS Equity VS FCFCANG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.41 indicates that CANG should not have too much problems paying its short term obligations.
The Current ratio of CANG (1.41) is comparable to the rest of the industry.
A Quick Ratio of 1.41 indicates that CANG should not have too much problems paying its short term obligations.
CANG has a Quick ratio of 1.41. This is amongst the best in the industry. CANG outperforms 85.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
CANG Yearly Current Assets VS Current LiabilitesCANG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

CANG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.42%, which is quite impressive.
The Revenue has grown by 46.68% in the past year. This is a very strong growth!
CANG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.00% yearly.
EPS 1Y (TTM)62.42%
EPS 3YN/A
EPS 5Y0%
EPS Q2Q%-330.19%
Revenue 1Y (TTM)46.68%
Revenue growth 3Y-41.04%
Revenue growth 5Y-11%
Sales Q2Q%1531.77%

3.2 Future

CANG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 104.33% yearly.
Based on estimates for the next years, CANG will show a decrease in Revenue. The Revenue will decrease by -4.86% on average per year.
EPS Next Y-248.42%
EPS Next 2Y104.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-23.84%
Revenue Next 2Y-4.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CANG Yearly Revenue VS EstimatesCANG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
CANG Yearly EPS VS EstimatesCANG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 10

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CANG. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 2.77, which indicates a rather cheap valuation of CANG.
100.00% of the companies in the same industry are more expensive than CANG, based on the Price/Forward Earnings ratio.
CANG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.67.
Industry RankSector Rank
PE N/A
Fwd PE 2.77
CANG Price Earnings VS Forward Price EarningsCANG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CANG is valued a bit more expensive than 70.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 129.34
CANG Per share dataCANG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

CANG's earnings are expected to grow with 104.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y104.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CANG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANGO INC/KY - ADR

NYSE:CANG (8/27/2025, 1:40:02 PM)

4.94

+0.03 (+0.61%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-27 2025-08-27
Inst Owners9.53%
Inst Owner Change1.56%
Ins Owners0.97%
Ins Owner ChangeN/A
Market Cap512.71M
Analysts82.86
Price Target8.16 (65.18%)
Short Float %3.59%
Short Ratio1.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)166.67%
PT rev (3m)166.67%
EPS NQ rev (1m)5.76%
EPS NQ rev (3m)5.76%
EPS NY rev (1m)-147.09%
EPS NY rev (3m)-145.7%
Revenue NQ rev (1m)2.8%
Revenue NQ rev (3m)2.8%
Revenue NY rev (1m)7.13%
Revenue NY rev (3m)14.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.77
P/S 2.05
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 0.96
EV/EBITDA 129.34
EPS(TTM)-0.03
EYN/A
EPS(NY)1.78
Fwd EY36.13%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.42
BVpS5.21
TBVpS5.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.04%
ROE 0.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.17%
GM 13.27%
FCFM N/A
ROA(3y)-3.88%
ROA(5y)3.21%
ROE(3y)-6.46%
ROE(5y)4.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y61.58%
OM growth 5Y-5.43%
PM growth 3YN/A
PM growth 5Y6.57%
GM growth 3Y-7.64%
GM growth 5Y-20.99%
F-ScoreN/A
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA 28.01
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z 1.08
F-ScoreN/A
WACC8.12%
ROIC/WACCN/A
Cap/Depr(3y)348.58%
Cap/Depr(5y)264.99%
Cap/Sales(3y)38.63%
Cap/Sales(5y)23.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.42%
EPS 3YN/A
EPS 5Y0%
EPS Q2Q%-330.19%
EPS Next Y-248.42%
EPS Next 2Y104.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.68%
Revenue growth 3Y-41.04%
Revenue growth 5Y-11%
Sales Q2Q%1531.77%
Revenue Next Year-23.84%
Revenue Next 2Y-4.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-162.18%
EBIT growth 3Y-4.73%
EBIT growth 5Y-15.84%
EBIT Next Year29.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-220.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-130.21%
OCF growth 3YN/A
OCF growth 5YN/A